英文名稱(chēng) Anti-CCL20/MIP3 alpha

中文名稱(chēng) 巨噬細(xì)胞炎性蛋白MIP-3a抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來(lái)源 Rabbit

交叉反應(yīng) Human, Mouse, Rat

產(chǎn)品類(lèi)型 一抗

研究領(lǐng)域 細(xì)胞生物 免疫學(xué)

蛋白分子量 predicted molecular weight: 8.6kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanCCL20

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 macrophage inflamatory protein 3 alpha; chemokine(C-C motif) ligand 20; C-C motif chemokine 20; Small-inducible cytokine A20;Macrophage inflammatory protein 3 alpha; MIP-3-alpha; Liver andactivation-regulated chemokine; CC chemokine LARC; Beta chemokine exodus-1;CCL20; LARC; SCYA20.